Actively Recruiting
Comparison of Vertebropexy Versus Conventional Decompression or Fusion Surgery for Degenerative Lumbar Spinal Disease: A Randomized Controlled Trial
Led by Balgrist University Hospital · Updated on 2025-02-13
164
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The trial investigates the treatment of degenerative lumbar spinal disease, focusing on the need for additional fusion surgery compared to the risk of revision surgery. It evaluates a new ligamentous fixation technique called vertebropexy, which aims to stabilize the spine without immobilizing segments, potentially reducing complications common with traditional spinal fusion. This randomized controlled trial seeks to produce convincing long-term results to support vertebropexy as an alternative to established surgeries like decompression and fusion. Participants receive one of several surgical procedures. These include microsurgical lumbar laminotomy with partial facet joint removal while preserving midline structures, decompression combined with vertebropexy using ligament allografts or sutures, and decompression with instrumented fusion using pedicle screws and fusion devices. The choice of procedure depends on the patient's condition. The trial compares vertebropexy with conventional decompression or fusion surgery. During the study, participants are monitored for two years after surgery. Researchers assess disability using the Oswestry Disability Index, pain levels, symptom function, satisfaction, quality of life, revision surgeries, complications, surgery duration, blood loss, hospital stay length, and use of analgesia and physical therapy. These evaluations help determine the effectiveness and risks of vertebropexy versus standard treatments, with a total follow-up extending up to two years post-operation.
CONDITIONS
Brief Title
Vertebropexy - Randomized-controlled Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Single-level or two-level lumbar spinal surgery needed
- Indication for decompression surgery with spinal canal stenosis and stable degenerative listhesis without facet joint effusion ≥ 2mm
- Indication for fusion surgery with spinal canal stenosis and unstable degenerative listhesis with facet joint effusion ≥ 2mm, foraminal stenosis with degenerative listhesis, or segmental disc degeneration
- Ability to understand German language
You will not qualify if you...
- Surgery indication due only to disc herniation, fractures, lytic listhesis, or tumor
- Patients undergoing revision surgery for infection
- Revision surgery on the same spinal level if bony structures were removed (e.g. prior laminectomy or midline decompression)
- Revision surgery after prior fusion surgery
- Inability to understand the study due to language or cognitive issues
- Expected clinical follow-up less than 6 weeks after inclusion
- Participation in other clinical trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Perioperative period
Participants undergo surgical treatment for degenerative lumbar spinal disease including decompression, fusion, or vertebropexy procedures with immediate post-operative care.
1 surgical visit and hospital stay
Duration - Up to 2 years postoperative
Participants are monitored and assessed for recovery, complications, and effectiveness of the surgical intervention.
Regular follow-up visits as scheduled over 2 years
Trial Site Locations
Total: 1 location
1
Balgrist University Hospital
Zurich, Switzerland, 8008
Actively Recruiting
Research Team
M
Mazda Farshad, MD
S
Sabrina Catanzaro, RN
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4